TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker's administration will implement "most favored nations" drug pricing, ensuring Americans pay the lowest price for drugs compared to other developed countries. Some prescription drug prices will be reduced almost immediately by 50% to 90%. Big Pharma must voluntarily comply or the federal government will ensure equal pricing. To accelerate price reductions, the administration will cut out the middlemen to facilitate direct drug sales to American citizens at the most favored nation price. The speaker believes the middlemen are worse than drug companies because they don't make a product but make a fortune.

Video Saved From X

reSee.it Video Transcript AI Summary
Healthcare companies will likely maintain similar profits despite global changes because it's a redistribution of wealth, not a reduction. Europe and the rest of the world will pay slightly more, while America will pay significantly less. This is due to America's smaller population relative to the global population. The top line revenue for healthcare companies will remain consistent, but the distribution of payments will shift globally.

Video Saved From X

reSee.it Video Transcript AI Summary
One breast cancer drug costs over $16,000 per bottle in America. The same drug, from the same factory and company, costs one sixth the price in Australia. In Sweden, the identical product costs one tenth the American price.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker claims the United States spends $1,126 per capita on drugs, while Britain spends about $240, approximately one-fifth of the U.S. figure, a trend seen across Europe. The speaker says drug companies claim America must pay for pharmaceutical innovation. President Trump is quoted as saying European partners need to increase their drug payments to cover their share of innovation, asserting the U.S. should no longer subsidize it. The speaker concludes that if Europeans raised drug prices by 20%, the resulting $10 trillion could be spent on innovation, improving global health.

Video Saved From X

reSee.it Video Transcript AI Summary
Former President Trump claims that he was the only president to take on big pharma, but Joe Biden canceled his toughened pharmaceutical policies. Trump signed an executive order to ensure that the US government pays the same price for pharmaceuticals as other countries, saving American patients billions of dollars. However, Biden reversed this order, allowing other countries to negotiate lower prices while Americans pay high prices. Trump promises that if he is reelected, he will sign an executive order to end this unfair practice and make Big Pharma lower prices for American patients. He believes that rescinding his original order shows the power of Big Pharma, but he is determined to deliver savings for seniors and all American patients.

Video Saved From X

reSee.it Video Transcript AI Summary
Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the current system was fair, even though the reasons why were not widely understood.

Video Saved From X

reSee.it Video Transcript AI Summary
Pharmaceutical companies claimed research and development costs had to be borne by America alone, which effectively meant American patients were subsidizing socialist healthcare systems in places like Germany and the European Union. The speaker believes the European Union is nastier than China and has treated the U.S. unfairly. However, the speaker asserts that the U.S. now holds all the cards and expects the European Union to concede.

Video Saved From X

reSee.it Video Transcript AI Summary
The administration will secure "most favored nations" drug pricing, meaning Americans will pay the lowest price for drugs paid in other developed countries. Some prescription drug prices will be reduced almost immediately by 50 to 90%. Big Pharma will either abide by this principle voluntarily, or the federal government will ensure Americans pay the same price as other countries. To accelerate price reductions, the administration will cut out the middlemen and facilitate the direct sale of drugs at the most favored nation price directly to American citizens. The middlemen are considered worse than the drug companies because they don't make a product but make a fortune.

Video Saved From X

reSee.it Video Transcript AI Summary
Pharmaceutical companies generate over two-thirds of their profits in the United States, despite the U.S. accounting for only 4% of the world's population. The speaker expresses respect for pharmaceutical companies and their leadership. They believe these companies successfully convinced people for many years that the existing system was fair, even though the reasons why were not well understood. The speaker claims to have figured out the reasons behind this.

Video Saved From X

reSee.it Video Transcript AI Summary
Pharmaceutical companies claimed high R&D costs had to be borne solely by America, effectively subsidizing socialist healthcare systems in countries like Germany and the European Union. The speaker believes the European Union is "nastier than China" and has treated the U.S. unfairly, but predicts they will concede because the U.S. "has all the cards."

Video Saved From X

reSee.it Video Transcript AI Summary
American taxpayers fund basic and late-stage clinical research for the entire world, largely through the NIH. While Europe and private foundations contribute, the NIH is the single largest global investor in basic science and applied research. Higher U.S. drug prices also fund the phase three trials and R&D efforts conducted by drug companies. Therefore, American taxpayers are essentially the world's piggy bank for almost all of the research pipeline.

Video Saved From X

reSee.it Video Transcript AI Summary
Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

Video Saved From X

reSee.it Video Transcript AI Summary
Robert F. Kennedy Jr. praises President Trump for addressing the discrepancy between US and European drug prices, a promise unfulfilled by previous Democratic leaders due to pharmaceutical industry influence. Kennedy claims there is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member, and the industry spends three times more on lobbying than any other. Kennedy states that Trump cannot be bought and is standing up to oligarchs, unlike other politicians. He notes that the US, with 4.2% of the world's population, accounts for 75% of pharmaceutical company revenues, spending $11.26 per capita on drugs compared to Britain's $240. Kennedy says Trump is asking European partners to increase their drug payments to fund innovation, suggesting a 20% increase would free up $10 trillion for innovation and improve global health.

Video Saved From X

reSee.it Video Transcript AI Summary
We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Video Saved From X

reSee.it Video Transcript AI Summary
Americans are prescribed around £7.7 million worth of antibiotics annually, which is equivalent to over 800 prescriptions for every 1,000 people. Surprisingly, approximately 80% of the population receives antibiotics in a given year.

Video Saved From X

reSee.it Video Transcript AI Summary
American patients were subsidizing socialist healthcare systems in the European Union. The European Union is nastier than China, but they will come down a lot. The U.S. has all the cards because the EU treated the U.S. unfairly. The EU sells the U.S. 13 million cars, but the U.S. sells them none. The EU sells the U.S. their agricultural products, but they don't take U.S. products. Because of this unfairness, the EU will have to pay more for healthcare, and the U.S. will have to pay less.

Video Saved From X

reSee.it Video Transcript AI Summary
One breast cancer drug costs Americans over $16,000 per bottle. The same drug, from the same factory, manufactured by the same company, costs one-sixth the price in Australia. In Sweden, the identical product costs one-tenth the price.

Video Saved From X

reSee.it Video Transcript AI Summary
A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker highlights the significant price difference, noting one person paid a small amount for the same shot in the UK. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world, according to the speaker, who questions the reason for this disparity.

Video Saved From X

reSee.it Video Transcript AI Summary
Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

Video Saved From X

reSee.it Video Transcript AI Summary
A common asthma drug costs almost $500 in America, but less than $40 in The United Kingdom. The speaker stated that an individual in the UK paid a small amount for their shot, contrasting sharply with the $500 cost in the US. The weight loss drug Ozempic costs 10 times more in The United States than in the rest of the developed world. The speaker questions the reason for this disparity.

Video Saved From X

reSee.it Video Transcript AI Summary
Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

Video Saved From X

reSee.it Video Transcript AI Summary
Americans pay significantly more for prescription drugs than other countries, sometimes up to 10 times more. Pharmaceutical companies generate two-thirds of their profits in the U.S., effectively making Americans subsidize healthcare in other countries. The administration is introducing a "most favored nation" pricing model, ensuring the U.S. pays the lowest price available globally for drugs. For example, a breast cancer drug costing over $16,000 in the U.S. is a fraction of that price in Australia and Sweden. Similarly, an asthma drug costs almost $500 in the U.S. but less than $40 in the UK. The plan involves directing investigations into foreign nations that block drug products unless they accept low prices, and the U.S. will defend drug companies from unfair pricing demands. The administration aims to cut out middlemen and facilitate direct drug sales at the most favored nation price. If companies don't comply, the U.S. will use its trade powers and open the market to safe, legal drug imports.

Video Saved From X

reSee.it Video Transcript AI Summary
Healthcare companies will likely make the same amount of money because it's a redistribution of wealth across the world, not just the European Union. Europe and the rest of the world will pay a little more, while America will pay a lot less. This is due to America having a smaller population compared to the entire world. The top line for healthcare companies could remain the same, but it will be distributed differently.

Video Saved From X

reSee.it Video Transcript AI Summary
Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. This issue was considered radioactive, but President Trump addressed it despite past contributions from pharmaceutical companies, which may have totaled $100,000,000. Unlike other politicians, Trump cannot be bought and is standing up for the American people. Despite claims from figures like Elizabeth Warren and Robert Reich that President Trump is on the side of the oligarchs, no president has been more willing to stand up to them than President Donald Trump. The speaker expressed pride in the President's courage and willingness to stand up for the American people.

PBD Podcast

"Big Pharma Is Organized Crime" - Whistleblower Peter C. Gøtzsche REVEALS Pharma’s Dirty Secrets
Guests: Peter C. Gøtzsche
reSee.it Podcast Summary
Pharma’s business model, Peter C. Gøtzsche argues, is organized crime. The pattern shows drug companies repeatedly committing crimes, bribing politicians and top officials, and paying off doctors to influence research and marketing. He notes that some of the largest drug firms have been fined billions, yet profits from sales exceed those penalties, allowing corrupt practices to continue. He says corruption spans research, marketing, and regulation, citing bribery of FDA commissioners and health ministers and broad influence over physicians. He contrasts the United States with Europe, noting U.S. healthcare consumes about 18% of GDP and relies on middlemen and aggressive drug use, while Nordic public systems offer universal care. He contends prescription drugs are a leading cause of death, including opioids, Motrin, and psychiatric medications, and that reducing their use by up to 90% could yield a healthier population. Beyond drugs, the interview turns to psychiatry and diagnosis. The guest criticizes the DSM for expanding medical labeling of ordinary experiences into disorders, calling ADHD a non-existent natural category and joking about a parade of diagnoses that would cover the middle. He recounts a dinner where four people tested positive for ADHD on a casual test, showing how easily psychiatric labels proliferate. He recalls warnings from veteran psychiatrists about overreliance on drugs for mental health and advocates psychotherapy as an alternative. Later, the discussion shifts to antidepressants, where studies show minimal placebo benefit and frequent sexual side effects, with some reports suggesting increased suicidality. The conversation then dives into vaccines and public health, with the guest expressing skepticism about licensing and mandates. He discusses the measles vaccine as life-saving in some cases but argues that screening and vaccination programs can yield mixed results, including cases where vaccination protocols might not extend life expectancy and can drive overtreatment. He addresses the HPV vaccine controversy, presenting data from internal reports and his book on Merck and drug regulator practices. He also critiques mammography screening, arguing that it does not reduce total mortality and can lead to unnecessary procedures. He has written about deadly psychiatry and organized denial, and emphasizes open scientific debate.
View Full Interactive Feed